Delivery Order SPE2DB20D9331-SPE2DB25FL1U9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $4,166.24, was awarded on June 2, 2025, with an ultimate completion date of June 24, 2025. The contract utilizes no set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,019.25 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order represents a purchase under DLA's larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at approximately $500 million and valid through November 2026. The award carries no set-aside designation, allowing the woman-owned small business...
- The Defense Logistics Agency awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This award, issued on September 8, 2025, with an ultimate completion date of September 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,249.24 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on September 23, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 15, 2025, represents a single delivery against DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. The award carries no set-aside designation, allowing the woman-owned small business based in Park Ridge, Illinois to compete directly...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a specific product requisition issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- SPE2DB20D9331Indefinite Delivery Contract
- SPE2DB20D9331-SPE2DB25FL1U9Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems on August 21, 2025, with an ultimate completion date of September 12, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is the prime contractor on this firm fixed-price delivery order, which carries no set-aside designation. This award represents a discrete delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide. Mirena systems are intrauterine contraceptive devices that provide long-acting reversible contraception, typically used in military and federal healthcare settings to support reproductive health services for military personnel and dependents. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to competitively secure multiple delivery orders for branded and generic prescription drugs, biologics, medical consumables, and specialty medications. The company's extensive portfolio of federal contract awards demonstrates its capability to reliably deliver diverse pharmaceutical products directly to Department of Defense healthcare facilities across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/21/25 |